Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Eden

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Eden head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 2 · Grade A−

Eden

Visit Eden Full brief →

FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 91 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Eden a bad call — it's best for people comparing a monthly compounded glp-1 program who want clear recurring charges and will review the provider and regulatory information before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
89
Supply Reliability
95
92
Transparency
90
93
Access Breadth
93
90
Clinical Oversight
92
92
Track Record
88
89
CoreAge RxBrief Score 94 · 91Eden

Price, coverage & the tracker

CoreAge RxEden
Brief Score94/100 (A)91/100 (A−)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$99/mo

No separate membership fee advertised.

Same recurring rate; no long-term contract advertised.

Full price details

$99/month for compounded semaglutide on the current GLP-1 program; no separate membership fee or long-term contract advertised

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$129/mo

No separate membership fee advertised.

Same recurring rate; no long-term contract advertised.

Full price details

$129/month for compounded tirzepatide on the current GLP-1 program; no separate membership fee or long-term contract advertised

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableFallingprice falling

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Eden: Current GLP-1 pages show $99/$129 each month, replacing the former separate-membership structure; confirm your selected program.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.